
Paradigm’s Kurt Mussina discusses why scale should drive operational efficiency, not consolidation into single-site studies.
• How to decide which devices are best-suited for patients participating in a clinical study • Data transmission and interaction from wearables during the study • Regulatory considerations for wearable devices across different countries/ geographical regions






